Samsung Biologics reports provisional interim results of PolyPeptide tender offer
Samsung Biologics, via Samsung Peptide, released a provisional interim result for its public tender offer for PolyPeptide registered shares. The offer targets all publicly held PolyPeptide shares listed on SIX under PPGN. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial